New inflammatory biomarker predicts elevated thrombosis risk in cancer patients

September 26, 2018, Medical University of Vienna
blood
Credit: Wikimedia Commons

Cancer patients are known to have an increased risk of thrombosis. As part of the CATS study, MedUni Vienna researchers have now investigated a correlation between an activated immune system in cancer patients and their risk of thrombosis. It was found that citrullinated histone 3, known as "H3Cit", a protein released into the blood by specialised immune cells, correlates with an elevated risk of thrombosis. The results of the study have been published in the Journal of Thrombosis and Haemostasis.

Venous thromboembolism – occlusion of venous blood vessels – is a known complication in cancer patients. Cancer patients have an approximately 4 – 7 times higher risk of thromboembolism, depending upon the type, stage and mode of treatment of the tumour. Blood-thinning drugs can be given prophylactically but these are not entirely without risk, since they affect the physiology of blood clotting and increase the risk of bleeds. The researchers believe that, to avoid exposing patients to further unnecessary complications, it would be preferable to be able to predict their individual risk more accurately.

A research group, led by biologist Lisa-Marie Mauracher and doctors Johannes Thaler, Cihan Ay and Ingrid Pabinger from the Division of Hematology and Hemastasology at MedUni Vienna's Department of Medicine I, has now studied the behaviour of a subgroup of , neutrophil granulocytes, and their influence upon increased thrombosis risk in .

Neutrophil granulocytes are part of the and their function is to identify and destroy microorganisms. One of their characteristics is that they release their DNA, which spreads like a net to trap and fight microorganisms. In addition to their role in immune defence, these DNA nets or traps are also involved in the development of thrombosis, since platelets (thrombocytes) get caught in the traps, are activated and can lead to vascular occlusion. Citrullinated histone 3 (H3Cit), a component of DNA traps, released into the , is measured to allow a more accurate analysis of the relationship between DNA traps and the development of thrombosis.

For the first time, the study has now enabled MedUni Vienna researchers to confirm their initial hypothesis, namely that the H3Cit protein is associated with an elevated risk of thrombosis. Says Mauracher: "This also indicates a correlation between and inflammation. This parameter can potentially be used in diagnostic procedures in the future."

Explore further: Cancer increases the risk of heart attacks, strokes and vascular occlusions

More information: L.-M. Mauracher et al. Citrullinated histone H3, a biomarker of neutrophil extracellular trap formation, predicts the risk of venous thromboembolism in cancer patients, Journal of Thrombosis and Haemostasis (2018). DOI: 10.1111/jth.13951

Related Stories

Cancer increases the risk of heart attacks, strokes and vascular occlusions

June 25, 2018
It is well known that pre-existing cancer is a significant risk factor for venous thrombosis. What was hitherto unclear was whether cancer also has a negative impact upon the risk of heart attacks, strokes or occlusions of ...

Cause of thrombosis in patients with malignant brain tumours discovered

March 16, 2017
Patients with malignant brain tumours have an increased risk of thrombosis. Up until now we did not understand the mechanisms behind this. An interdisciplinary study conducted under the direction of Julia Riedl and Cihan ...

'Risk calculator' developed for venous thromboses

August 14, 2013
In Austria, around 15,000 people a year develop a venous thrombosis, the occlusion of a vein that can result in a pulmonary embolism. A clot breaks free from a vein and travels via the bloodstream to the lungs, where it blocks ...

Patients with myeloproliferative neoplasms have a significantly increased risk for arterial and venous thrombosis

January 15, 2018
Patients with myeloproliferative neoplasms (MPNs) have a significantly increased rate of arterial and venous thrombosis, with the highest rates occurring at and shortly after diagnosis. The findings of a population-based ...

Increased risk of thrombosis in myeloproliferative neoplasms

January 16, 2018
(HealthDay)—Patients with myeloproliferative neoplasms (MPNs) have increased risk of arterial thrombosis and venous thrombosis across all age groups and MPN subtypes, according to a study published online Jan. 16 in the ...

Major illness increases venous thrombosis risk

November 3, 2012
(HealthDay)—People with major illnesses, including liver or kidney disease, rheumatoid arthritis, multiple sclerosis, heart failure, hemorrhagic stroke, or arterial thrombosis, have an increased risk of venous thrombosis ...

Recommended for you

Immunotherapy combo not approved for advanced kidney cancer patients on the NHS

December 14, 2018
People with a certain type of advanced kidney cancer will not be able to have a combination of two immunotherapy drugs on the NHS in England.

New drug seeks receptors in sarcoma cells, attacks tumors in animal trials

December 13, 2018
A new compound that targets a receptor within sarcoma cancer cells shrank tumors and hampered their ability to spread in mice and pigs, a study from researchers at the University of Illinois reports.

Surgery unnecessary for many prostate cancer patients

December 13, 2018
Otherwise healthy men with advanced prostate cancer may benefit greatly from surgery, but many with this diagnosis have no need for it. These conclusions were reached by researchers after following a large group of Scandinavian ...

Combining three treatment strategies may significantly improve melanoma treatment

December 12, 2018
A study by a team led by a Massachusetts General Hospital (MGH) investigator finds evidence that combining three advanced treatment strategies for malignant melanoma—molecular targeted therapy, immune checkpoint blockade ...

Researchers use computer model to predict prostate cancer progression

December 12, 2018
An international team of cancer researchers from Denmark and Germany have used cancer patient data to develop a computer model that can predict the progression of prostate cancer. The model is currently being implemented ...

Higher risk of heart attack on Christmas Eve

December 12, 2018
The risk of heart attack peaks at around 10pm on Christmas Eve, particularly for older and sicker people, most likely due to heightened emotional stress, finds a Swedish study in this week's Christmas issue of The BMJ.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.